Package 1 - Reagents for lung cancer diagnostics by next-generation sequencing
This tender has been awarded
The contracting authority has selected an awardee for this tender.
About This Opportunity
TranslatedThis tender concerns Package 1, which focuses on the procurement of reagents specifically for the diagnosis of lung cancer. The diagnostic method specified is next-generation sequencing (NGS). NGS is an advanced technology used for genetic analysis, allowing for the identification of mutations and biomarkers relevant to cancer. The contracting authority requires high-quality reagents suitable for performing these complex molecular diagnostic tests. The tender will detail the specific types and quantities of reagents needed, as well as performance and quality standards. This procurement is crucial for advancing diagnostic capabilities in oncology, enabling personalized treatment approaches for lung cancer patients.
This is a supplies contract in the health and medical services sector. Located in Poland, Europe, this opportunity is open to firms and consortiums.
Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
Auto-translated from PolishReagents for lung cancer diagnostics by next-generation sequencing
Data provenance
This notice is sourced from TED - Tenders Electronic Daily (EU) and was originally published on March 31, 2026. Last refreshed 105 days ago. Original language: Polish. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About Dolnośląskie Centrum Onkologii, Pulmonologii i Hematologii
Dolnośląskie Centrum Onkologii, Pulmonologii i Hematologii has issued 147 procurement notices on BidsFactory, including 6 currently open and 32 awarded contracts. Activity concentrates in Health & Medical, Information & Communication Technology, and General Supplies & Services. All notices are published for Poland. Notices are distributed via TED - Tenders Electronic Daily (EU) and Poland e-Zamówienia. Most recent publication: November 17, 2026.
Dolnośląskie Centrum Onkologii, Pulmonologii i Hematologii: buyer profile, tenders and awardsFrequently asked questions about this tender
Is this tender still open?
No — the contracting authority has selected an awardee for this notice. The record is kept for transparency and market intelligence.
Who is the contracting authority?
This notice was issued by Dolnośląskie Centrum Onkologii, Pulmonologii i Hematologii in Poland. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
Where will the contract be performed?
The contract is for delivery in Poland. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
How can I submit a bid?
Visit TED - Tenders Electronic Daily (EU) to access the full notice, required documents, and submission instructions provided by the contracting authority.
Find tenders like this automatically
Premium shows the full details of every tender like this one and alerts you instantly when a new one is published.
Sectors & Categories
Contracting Authority
Contact
Companies That Won Similar
Companies with awards in Health & Medical in Poland